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Abstract
Background: The nicotinic acetylcholine receptors form a large and diverse family of acetylcholine gated ion
channels having diverse roles in the central nervous system. Maturation of nicotinic acetylcholine receptors is a
complex and inefficient process requiring assistance from multiple cellular factors including RIC-3, a functionally
conserved endoplasmic reticulum-resident protein and nicotinic acetylcholine receptor-specific chaperone. In
mammals and in Drosophila melanogaster RIC-3 is alternatively spliced to produce multiple isoforms.
Results: We used electrophysiological analysis in Xenopus laevis oocytes, in situ hybridization, and quantitative
real-time polymerase chain reaction assays to investigate regulation of RIC-3’s expression and splicing and its effects
on the expression of three major neuronal nicotinic acetylcholine receptors. We found that RIC-3 expression level and
splicing affect nicotinic acetylcholine receptor functional expression and that two conserved RIC-3 isoforms express in
the brain differentially. Moreover, in immune cells RIC-3 expression and splicing are regulated by inflammatory signals.
Conclusions: Regulation of expression level and splicing of RIC-3 in brain and in immune cells following inflammation
enables regulation of nicotinic acetylcholine receptor functional expression. Specifically, in immune cells such regulation
via effects on α7 nicotinic acetylcholine receptor, known to function in the cholinergic anti-inflammatory pathway, may
have a role in neuroinflammatory diseases.
Keywords: Acetylcholine, RIC-3, Protein maturation, Alternative splicing, Disordered protein, Nicotinic acetylcholine
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Background
Nicotinic acetylcholine receptors (nAChRs) are a diverse
family of pentameric neurotransmitter-gated ion channels.
A total of 17 nAChR subunits (α1-α10 subunits which
contain adjacent cysteines required for ligand binding, β1-
β4, γ, δ, and ε) have been identified in vertebrates; nine
subunits (α2-α7 and β2-β4) express in the mammalian
nervous system. These subunits co-assemble to generate a
wide variety of mostly heteromeric, cation-selective chan-
nels with diverse properties and expression patterns.
Several, mostly non-synaptic—as opposed to direct, fast
excitatory transmission—roles of nAChRs have been stud-
ied; among them, modulation of neurotransmitter release
by presynaptic nAChRs is their most prevalent and well-
studied role in the CNS [10, 11, 24] as well as roles in
non-excitatory cells including an important role in con-
trolling inflammation of the α7 nAChR [4, 21].
Maturation of nAChRs is a complex and time consum-
ing process [29]. Several proteins were shown to affect
functional expression and properties of nAChRs, includ-
ing RIC-3, which significantly affects functional expression
of multiple nAChRs and the recently identified NACHO
protein which like RIC-3 is an ER-resident chaperone
which enables functional expression of α7 nAChR in
mammalian cell lines and is required for its expression in
hippocampal neurons [17, 29, 30, 33].
RIC-3 is conserved for sequence and function [18, 19,
29]. In humans [19] multiple transcripts were found which
show differential expression. These transcripts encode for
multiple isoforms including a long full length (RIC-3 FL)
transcript encoding for two membrane spanning domains
followed by a coiled-coil domain and a shorter isoform
lacking the coiled-coil domains (RIC-3 TM) [19, 29].
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Alternative splicing of RIC-3 is seen across evolution and
has been studied in detail in Drosophila [22]. Specifically
the short TM isoform is conserved in mammals and its
expression is likely to have functional implications [2, 3].
An additional mechanism likely to regulate RIC-3 function
is its quantity, as high RIC-3 expression was shown to be
detrimental, possibly due to formation of non-functional
nAChR subunit-containing aggregates [1, 27, 32].
Effects of RIC-3 are receptor specific: While RIC-3 was
shown to promote maturation of four different nAChRs in
C. elegans, and is likely to be essential for functional expres-
sion of α7 nAChR, RIC-3 had either positive or negative
effects on the two neuronal nAChRs α3β4 and α4β2
depending on the experimental system [18, 19, 22, 33].
Many neurons express several receptor subunits; enabling
assembly of several different neuronal nAChRs [16]. Thus,
identification of mechanisms preferentially promoting or
inhibiting functional expression of one receptor relative to
others is of interest.
Here we examine effects of expression level of two con-
served alternatively spliced RIC-3 isoforms, FL and TM,
on the three neuronal nAChRs: α3β4 – best characterized
for its vital role in the autonomic nervous system [34],
α4β3 – the most common nAChR in the CNS, having
high affinity for ACh, and mediating the effects of smok-
ing [14, 25], and α7 – which uniquely preferentially forms
homomers, is characterized by low-affinity ACh binding,
is expressed widely, is highly permeable to calcium, and
strongly affects inflammation in immune cells [20, 26, 31].
We show that for both isoforms RIC-3-to-receptor ratio
strongly affects receptor maturation in a receptor-specific
manner. Furthermore, we show that expression and spli-
cing of ric-3 is regulated in mice, providing a new mech-
anism for regulating nAChR expression.
Results
RIC-3-to-subunit ratio affects nAChR functional expression
Previous studies have found conflicting effects of RIC-3,
inhibited vs. enhanced functional expression, on α3β4 and
α4β2 nAChR functional expression [19, 22]. In order to
explore the hypothesis that the RIC-3-to-receptor subunits
ratio may play a role in RIC-3’s effect on functional expres-
sion, we conducted the first systematic analysis of the effect
of the full length (FL) RIC-3 isoform on these nAChRs,
using the heterologous expression system Xenopus laevis
oocytes (for a description of mouse RIC-3 transcripts see
Additional file 1: Figure S1).
We co-injected cRNA of FL ric-3 with the cRNA of α4
and β2 subunits, or α3 and β4 subunits into X. laevis oo-
cytes for electrophysiological analysis. Subunits were al-
ways injected at 5 ng/oocyte, while ric-3 was injected in
amounts ranging from 5 ng/oocyte to 0.0005 ng/oocyte.
Our results (Fig. 1a and b) show current amplification at
a relatively robust range of low to mid concentrations of
ric-3 for α4β2 and weaker less robust amplification for
α3β4 at similar concentrations (0.0005–0.01 ng/oocyte
and 0.0005–0.25 ng/oocyte, respectively). Inhibition was
seen at only two concentrations checked for α4β2
(0.1 ng/oocyte and 5 ng/oocyte), while inhibition was
more robust, spanning an entire order of magnitude, at
the highest concentrations checked (0.5–5 ng/oocyte)
for α3β4. For all receptors, not all concentrations tested
are shown; a number of the lower concentrations pro-
duced very similar results and so only representative low
and mid concentrations are shown.
In similar analysis of effects of RIC-3-to-α7 subunit ratio
(Fig. 1c), co-expression of α7 with FL showed amplified
currents at a narrow, high concentration of ric-3 (2.5 ng/
oocyte) and, for the first time, inhibition of currents was
shown at low concentrations (0.0005–0.05 ng/oocyte). This
novel finding of inhibition at low concentrations was
robust, spanning two orders of magnitude. Interestingly,
analysis of the effects of the FL human RIC-3 isoform
showed no significant inhibition at any of the concentra-
tions examined (Additional file 2: Figure S2). Results in
Additional file 2: Figure S2 show inhibition by mouse FL
RIC-3 at the highest concentration used, a result similar
to previously described effects of high RIC-3-to-α7 ratio
[1], but different from what is seen in Fig. 1c. Differences
in the results shown in Fig. 1c compared to Additional file
Fig. 1 Effects of different amounts of FL on ACh-stimulated currents through each of three nAChRs: a α4β2; b α3β4; and c α7. Results were normalized
to currents recorded in oocytes expressing the respective receptors in the absence of RIC-3 in the same experiment. Each bar represents 10–20 oocytes
from 2 to 3 independent X. laevis. The y-axis ordinates are on a log scale. * indicates a p value of less than 0.05; ** indicates a p value of less than 0.01
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2: Figure S2 are likely due to different cRNA quality or
variability in protein expression between experiments.
RIC-3 alternative splicing’s effects on nAChR functional
expression
Alternative splicing of RIC-3 generates multiple isoforms
[19, 22, 29]. Two conserved isoforms of RIC-3 are the
FL isoform (isoform a) and the transmembranal (TM)
isoform which includes the two transmembrane domains
of the FL isoform but does not include the C-terminal
coiled-coil domain [29]. This TM isoform (isoform d),
unlike other alternatively spliced human isoforms [29], is
also found in mice (for example, clone BU705427) [2]
and in swine (FS667185). For a description of mouse ric-
3 transcripts found in databases of full length transcripts
see Additional file 1: Figure S1. In humans this isoform is
represented by several human EST clones from multiple
tissues and its expression in mice is described below. To
explore whether mammalian alternative splicing of RIC-3 –
specifically, the presence or absence of the coiled-coil do-
main – affects RIC-3’s effects on nAChRs, we repeated the
systemic analysis described above, this time, co-expressing
the TM isoform together with nAChR subunits.
While co-expression of α7 with FL showed amplified
currents at a high concentration of FL RNA (Fig. 1c), co-
expression of α7 with TM showed inhibition of currents at
all concentrations (Fig. 2c). This is in contrast to α4β2
where currents were amplified or inhibited depending on
the amount of FL expressed, while no significant inhib-
ition was seen at any concentration of TM expression
(Fig. 2a), or to α3β4 where currents were amplified at low
concentrations of RIC-3 and inhibited at high concentra-
tions, regardless of RIC-3 isoform (Fig. 2b).
As amplifying effects on α7 nAChR are seen at a single
concentration of FL and no concentration of TM (Figs. 1c
and 2c) we checked whether differences in expression of
the two isoforms explain their different effects. To compare
expression levels of these isoforms we tagged both isoforms
with two copies of myc at the C-terminus. Using this tag
we found that the two isoforms express similarly (Fig. 3a).
Moreover, electrophysiology experiments show different
effects of RIC-3 FL vs. TM in spite of having similar expres-
sion levels in the same experiment (Fig. 3). Therefore we
can rule out protein stability or efficacy of translation
as the mechanism of RIC-3 isoforms’ differential effects
on nAChRs’ functional expression. We note that in
these experiments, the concentration where amplifica-
tion is seen is shifted relative to experiments with un-
tagged FL (Fig. 1c). This is likely to be a result of
differences in cRNA quality or of effects of the tag on
protein stability (Fig. 3b relative to Figs. 1c and 2c).
FL and TM isoforms of RIC-3 express in the brain
The different effects of the two RIC-3 isoforms examined
and the effect of RIC-3-to-receptor ratio on functional
expression of co-expressed nAChRs (Figs. 1 and 2) indicate
that there is likely to be a physiological significance to
mechanisms regulating alternative splicing and quantity of
RIC-3. To explore the functional implications of alternative
splicing in the mammalian brain we examined the expres-
sion patterns of the two isoforms in the brains of mice.
For this we used in situ hybridization using oligodeoxy-
nucleotide probes consisting of approximately 250 nucleo-
tides; these probes correspond to the antisense strand of
unique 3′ untranslated regions of the FL and TM isoforms,
and to an antisense strand region common of all known
isoforms (positive control, overlapping the first two exons
which are found in all known mouse transcripts, same as in
[19]) and its sense strand (negative control) (Fig. 4a and
Additional file 1: Figure S1). We found that both isoforms
indeed express in the naïve mouse brain and that expres-
sion may be regulated. Specifically, while the positive con-
trol probe was clearly visible throughout the hippocampus
and cerebellum (similarly to what was shown by [19]) and
the negative control probe was not visible anywhere in the
brain, the FL-specific probe showed a strong signal
throughout the hippocampus, CA1, CA2 and CA3 and
dentate gyrus (Fig. 4b) in all of the brains checked, and a
somewhat weaker signal in the cerebellum (Fig. 4d) of two
of the three brains. The TM-specific probe was visible in
Fig. 2 Effects of different amounts of TM on ACh-stimulated currents through each of three nAChRs: a α4β2; b α3β4; and c α7. Results were normalized
to currents recorded in oocytes expressing the respective receptors in the absence of RIC-3 in the same experiment. Each bar represents 10–20 oocytes
from 2 to 3 independent X. laevis. The y-axis ordinates are on a log scale. * indicates a p value of less than 0.05; ** indicates a p value of less than 0.01
Ben-David et al. Molecular Brain  (2016) 9:47 Page 3 of 9
the cerebellum (Fig. 4e) of all brains but only very weakly in
the hippocampus (Fig. 4c).
FL and TM isoforms of RIC-3 express differentially
Results above suggested that RIC-3 alternative splicing is
regulated. However, as in situ hybridization is a qualita-
tive rather than quantitative assay, we further evaluated
the extent of differential expression using qRT-PCR. For
this we assessed expression of FL and TM in the dis-
sected CNS regions of naïve young adult female mice.
We found that FL expression is greater than TM ex-
pression in all regions investigated by an order of magni-
tude (compare Fig. 5a to b), and that the amount of each
isoform expressed is significantly different in different
tissues. Specifically, FL expression was highest in the
cerebellum, followed by the spinal cord, hippocampus,
and finally prefrontal cortex where the difference was
statistically significant (p < 0.001) relative to cerebellum
according to ANOVA (Fig. 5a). TM expression was also
highest in the cerebellum, followed by the hippocampus,
prefrontal cortex and finally, spinal cord, all three of which
were lower significantly relative to cerebellum (p < 0.001)
according to ANOVA (Fig. 5b). Interestingly, while FL
expression was about 8.6 times greater than TM in the
cerebellum and 8.3 times greater in the hippocampus, the
difference was significantly greater in the prefrontal cortex
(18.5 times greater) and in the spinal cord (29.0 times
greater). Thus, both expression and splicing of RIC-3 are
likely to be regulated in a brain region-specific manner.
Expression level and splicing of RIC-3 in immune cells and
following inflammation
This study found that effects of RIC-3 on α7 nAChR are
strongly dependent on RIC-3-to-receptor ratio and on
ric-3 splicing (Figs. 1c and 2c). Previous studies found
that α7 plays an important role in immune cells [31].
Therefore, it was interesting to investigate regulation of
ric-3 expression and splicing in immune cells: mouse
spleen cells and RAW264.7 (a mouse macrophage cell
line), where α7 activation was previously shown to in-
hibit lipopolysaccharide (LPS)-dependent activation [31].
Similar to in the CNS, FL expression was higher than
TM in the spleens of naïve young adult female mice
(Fig. 6a). Overall, ric-3 expression was about two orders
of magnitude lower in the spleen relative to the CNS. In
RAW264.7 cells, overall expression of ric-3 was higher
Fig. 4 RIC-3 expression in mouse brain by in situ hybridization.
a Schematic representation of the transcripts encoding the FL and TM
isoforms and loci of the isoform-specific probes. Lines, introns, black filled
bars coding sequences, white filled bars non-coding (UTRs). Scale bar,
100 bp, size of non-coding sequences is not to scale. b representative
image of FL expression in hippocampus. c Representative image of TM
expression in hippocampus. d Representative image of FL expression in
cerebellum. e Representative image of TM expression in cerebellum
Fig. 3 Effects of TM and FL cannot be attributed to expression level.
a Representative Western Blot of the myc-tagged transcript-expressing
oocytes showing similar expression of FL and TM. A single oocyte’s
worth of homogenate prepared from an average of about 5 oocytes,
was run in each lane; the Western was repeated twice with nearly
identical results; b Electrophysiological recordings of ACh-stimulated
currents through α7, co-expressed with different amounts of myc-tagged
RIC-3 transcripts. Each bar represents 7–11 oocytes from 2 independent
X. laevis. The y-axis ordinates are on a log scale. * indicates a p value of
less than 0.05
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than in spleen cells but the FL to TM ratio was similar
to spleen cells and brain regions (Fig. 6b, time zero).
To examine the effects of pro-inflammatory stimuli on
ric-3 expression, RAW264.7 cells were stimulated with
25 ng/ml LPS and collected after 0, 24 and 48 h exposure
for RNA isolation, reverse transcription, and analysis by
qRT-PCR. At 0 h, expression of FL was about 10 times
great than TM expression (Fig. 6b). However, after 24 h
exposure to LPS, FL expression was significantly decreased
while TM expression was only mildly decreased, and after
48 h exposure FL expression almost returned to unexposed
levels and TM expression also mildly increased (Fig. 6b). In
other words, in RAW264.7 cells acute pro-inflammatory
stimuli inhibited ric-3 expression – far more significantly
FL expression than TM expression – which recovered with
prolonged exposure. Previous studies have shown pro-
inflammatory effects of LPS after 48 h, and even 72 h; thus
our results showing recovery of ric-3 expression after 48 h
are not likely to be a result of time limited effects of LPS or
to degradation of LPS [9, 13, 35].
Discussion
Taken together our results show that the effects of RIC-3
on nAChRs appear to depend on the RIC-3-to-receptor
ratio and on the particular receptor subtype. These results
reconcile previously conflicting reports of the effects of
human RIC-3 on α4β2 and α3β4 nAChRs, as previous
studies used a narrow range of RIC-3-to-receptor ratio
and thus missed inhibitory or amplifying effects of RIC-3
[7, 19, 24]. The sensitivity to RIC-3 quantity is likely to be
not only receptor-specific, but also species specific as no
inhibition was seen of α7 nAChR when co-expressed with
human RIC-3, in contrast to mouse RIC-3. In addition, by
using a wide range of mouse RIC-3 concentrations we also
saw inhibition of α7 nAChR at low concentrations for the
first time; this inhibition may be due to a minimum ratio of
RIC-3-to-α7 subunit being required for the amplifying
mechanism of RIC-3 on α7 nAChR, while below a certain
threshold the presence of RIC-3 is inhibitory; such inhib-
ition may be explained by RIC-3’s binding to individual
subunits preventing them from assembling on their own
while not facilitating receptor assembly via coiled-coil
domain dimerization, as suggested by Wang et al. [32];
dimerization which may require high RIC-3 concentration.
Structure function and bioinformatic analysis of RIC-3
suggested that it is a disordered protein [8]. Tompa et al.
[28] described that some intrinsically disordered proteins
elicit opposing (inhibiting and activating) action on differ-
ent partners or even the same partner molecule even via
the same site by adopting different conformations after
binding, and that the amount of disordered protein
expressed may be part of the mechanism for these
Fig. 5 RIC-3 expression in mouse brain by qRT-PCR. a FL and b TM expression in CNS regions of naïve mice. ** indicates a p value of less than
0.01; *** indicates a p value of less than 0.001 according to Students t-test comparing expression in each tissue to expression in the cerebellum.
Expression was tested using qRT-PCR for each isoform in each tissue of 10–12 mice. Expression values are normalized to GAPDH expression and
multiplied by a factor of 1,000 for convenience. Cerb = cerebellum; hip = hippocampus; pfc = prefrontal cortex; sc = spinal cord
Fig. 6 RIC-3 expression in a mouse spleen cells, and b RAW264.7 cells at 0, 24 and 48 h following exposure to LPS. * indicates a p value of less
than 0.05; ** indicates a p value of less than 0.01 according to two-way ANOVA with Bonferroni correction. Expression was tested using qRT-PCR
for each isoform in each of 6 spleens, or from each of three independent RAW264.7 experiments. Expression values are normalized to GAPDH
expression and multiplied by a factor of 10,000 for convenience
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opposing effects. Our results are, therefore, consistent with
the suggestion that RIC-3’s functions depend on its disor-
dered structure [8].
The current results also show that RIC-3 alternative
splicing affects nAChR functional expression. Specific-
ally, the coiled-coil domain may be uniquely necessary
for RIC-3’s amplifying effect on α7; a result consistent
with previously published results [32] showing that the
coiled-coil domain is essential for RIC-3’s positive effects
on α7 in cells that require RIC-3 for functional expres-
sion of α7. Moreover, our results suggest that the coiled-
coil domain is necessary for the inhibitory effects of
RIC-3 on α4β2 nAChR.
Together, our results suggest the regulation of RIC-3 ex-
pression and/or splicing is likely to have functional implica-
tion. Thus we explored the expression of the two conserved
ric-3 transcripts, FL and TM which have been analyzed
here for their effects on neuronal nAChRs, in mice. In situ
hybridization experiments with DIG-labeled probes allowed
us to identify specific brain structures where each isoform
expressed. However, while this method carries the advan-
tage of high spatial resolution within brain structures, and
general differences in signal strength were noted, it is not a
reliably quantitative method and is biased to highlight cell-
dense structures such as the hippocampus. In addition,
variability of ric-3 detection via in situ is evident by variabil-
ity between mice in this study and when comparing the
current in situ results to previously published results by our
lab [19] and to those in the Allen Brain Atlas. Specifically,
our previous analysis, unlike the current analysis, did not
detect ric-3 expression in the dentate gyrus [19]. In
addition, the Allen Brain Atlas studies showed different
partially overlapping expression patterns in two different
mice (http://www.brain-map.org/search/index.html?quer-
y=%40entrez_id%20320360); these two brains were hybrid-
ized with different probes: one of which is to the 3′
untranslated region found only in the longer FL transcript
(Additional file 1: Figure S1), and the other of which identi-
fies all known mouse isoforms other than TM including
the longer FL transcript.
To better analyze ric-3’s expression levels we used
qRT-PCR which while having lower spatial resolution, as
brain tissue must be dissected manually for experimen-
tation, provides more accurate quantitative data which
has been averaged over many animals. Taken together
these findings support that regulation of RIC-3 expres-
sion level and alternative splicing in a region specific
manner – co-localizing with different nAChRs – may
enable region-specific regulation of nAChR functional
expression. Particularly in neurons where expression of
receptor subunits overlaps, mechanisms regulating RIC-
3 expression level and/or splicing may preferentially pro-
mote or inhibit functional expression of one receptor
relative to another.
Similarly, in immune cells, where the nAChR α7 plays a
well-established role in the cholinergic anti-inflammatory
pathway [4], we found that RIC-3 expression and splicing
are regulated by a stimulus (LPS) inducing inflammation
and that FL is the more strongly regulated isoform. These
results together with the known dependence of α7 nAChR
expression on RIC-3 and the known importance of α7
nAChR in regulating inflammation suggest that regulation
of ric-3 expression and splicing may have a role in regulat-
ing inflammation. Moreover, the very narrow range of
concentrations at which mouse ric-3 enhances α7 nAChRs
functional expression enables strong effects of this regula-
tory mechanism either disinhibition if at resting levels of
ric-3 its high expression inhibits α7 functional expression
[1] or inhibition if resting levels enable its expression. As
previous work showed upregulation of α7 nAChR expres-
sion in the same RAW264.7, immune cells, following the
same pro-inflammatory stimuli the first possibility is more
likely [23].
Conclusions
We found that the effects of RIC-3 on nAChRs depend
on the RIC-3 alternatively spliced isoform and on the
RIC-3-to-receptor ratio; sensitivity to the latter in par-
ticular is both receptor-specific and RIC-3 isoform-
specific. We also found that alternatively spliced iso-
forms of RIC-3 express in the brain differentially. Taken
together we can propose a possible mechanism of RIC-
3’s effect on nAChRs: That the splicing and amount of
RIC-3 expressed create a complex mechanism for regu-
lating the amplification or inhibition of nAChR func-
tional expression. Furthermore, expression level and
splicing of RIC-3 in immune cells and following pro-
inflammatory stimulation suggests that this regulatory
mechanism, via regulation of α7 nAChR function plays a
role in regulating inflammation in a physiological setting




The mouse FL transcript (RIKEN clone A330090D22;
NCBI locus BB195671) was acquired from imaGenes in the
pFLCI vector, linearized with KpnI and transcribed in vitro
using T7 RNA polymerase. Mouse TM transcript (RIKEN
clone A230057E24; NCBI locus AK038724) was acquired
from imaGenes in the pFLCI vector, linearized with KpnI
and transcribed in vitro using T7 RNA polymerase. Rat α7
was inserted into pGEMH19, an oocyte expression vector
having X. laevis globin untranslated regions, linearized with
NheI and transcribed in vitro using T7 RNA polymerase.
Rat α4 [15] in pSGEM was linearized with SfiI and tran-
scribed in vitro using T7 RNA polymerase. Rat α3 [5] in
pSP64 was linearized with EcoRI and transcribed in vitro
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using SP6 RNA polymerase. Rat β2 [12] in pSGEM was lin-
earized with SfiI and transcribed in vitro using T7 RNA
polymerase. Rat β4 [6] in pBS(SK-) was linearized with
XhoI and transcribed in vitro using T3 RNA polymerase.
In vitro synthesis and injection of cRNAs into oocytes
was previously described [2]. Briefly, in vitro transcribed
and capped cRNAs were injected at final concentrations
of 0.1 μg/μl for nAChR subunits and 0.1–0.00001 μg/μl
for ric-3 isoforms.
Macroscopic currents were recorded one to five days
after injection, depending on the cRNA (1–2 days for
α3β4 and α4β2 and up to 5 days for α7); comparisons for
effects of ric-3 FL or TM quantity on a specific receptor
were all done on the same day. Cells were placed in a 2 ml
bath that was perfused with medium and penetrated with
two 0.5–1.5 MΩ 3 M KCl-filled glass microelectrodes
attached to a GeneClamp 500B amplifier (Axon Instru-
ments, Foster City, CA), using a two-electrode voltage
clamp with active ground configuration and an HS-2A
headstage (Axon Instruments). A Pentium 4 PC system
employing the pCLAMP9 (AxoScope) software (Axon
Instruments) was used for maintaining voltage clamp.
Cells were clamped at −70 mV. Oocytes with leak currents
<150 nA were used.
Electrodes were filled with 3 M KCl. The extracellular
recording solution contained ND96 (96 mM NaCl,
2 mM KCl, 5 mM Hepes, pH 7.5) with 5 mM MgCl.
The current and the voltage in the voltage-clamp circuit
were recorded simultaneously and were saved directly
onto the computer. 1 mM ACh agonist (Sigma-Aldrich)
was prepared and used to stimulate oocytes. Results are
presented as the mean ± SEM with n equal to the num-
ber of oocytes tested and N equal to number of different
frogs in each experiment.
Statistical analysis
Data analysis was conducted using Microsoft Excel after
removing outliers per Grubb’s Outlier Test. To reduce
noise due to variability in expression levels between differ-
ent experiments, the current amplitudes were normalized
to the average response for oocytes expressing only the
receptor without ric-3 in the same experiment. Student t-
test and ANOVA were used to determine significance, as
appropriate.
Western blot
RIC-3 (FL and TM) constructs for protein quantification
were prepared by tagging each transcript with two copies of
the myc gene at the C-terminus using Q5® Site-Directed
Mutagenesis Kit (New England Biolabs).
Oocytes were injected with 5 ng/oocyte α7 RNA and
0.35 ng, 0.65 ng, or 1.25 ng myc-tagged ric-3 RNA. On the
fifth day of expression, electrophysiology recordings were
made and then oocytes were homogenized by repetitive
pipetting in 25 μl/oocytes buffer (20 mM Tris-HCl
(pH 8.0), 100 mM NaCl, 1 % Triton X-100) with Complete
Mini, EDTA free, protease inhibitor mixture tablets (Roche
Applied Science) (1 tablet/7 ml of buffer). After 30 min on
ice, the homogenate was centrifuged at 4 °C. The super-
natant was aliquoted, and sample buffer (125 mM Tris, 4 %
SDS, 20 % glycerol, 0.2 % bromphenol blue, and 2 % β-
mercaptoethanol) was added at 1:3 buffer-to-sample ratio.
Proteins were separated on 10 % SDS-PAGE, transferred
to nitrocellulose membrane, and immunoblotted with poly-
clonal rabbit anti-myc 1:2000 (Abcam) followed by goat
anti-rabbit HRP 1:20000 (Jackson Immunoresearch).
In situ hybridization
The sequence of the oligodeoxynucleotide probes consisted
of approximately 250 nucleotides. The probes correspond
to anti-sense strands of unique 3′ untranslated regions of
the FL or TM isoforms (Fig. 4a), the positive and negative
controls corresponding to a region, encompassing the first
two exons, common to all isoforms were previously de-
scribed [19]. The probes were synthesized, briefly, by linear-
izing the vector-insert construct and using the resulting
template for RNA synthesis using DIG-labeled ribonucleo-
tides. Probes were purified using RNeasy Mini Kit for RNA
cleanup (Qiagen) and quality assessment performed by
agarose gel electrophoresis.
The protocol was repeated on the brains of three female
ICR mice purchased from Harlan Laboratories, ranging
from 10 to 21 weeks of age at the time of sacrifice. Brain
tissue was fixed in 4 % paraformaldehyde, paraffin sliced,
rehydrated, treated with proteinase K and refixed with 4 %
formaldehyde.
Hybridization with DIG-labeled RNA probes was per-
formed by dripping 100 μl prewarmed hybridization mix
+ 1 μl probe per slide and placed upright in a humid
chamber containing Watman paper drenched with 50 %
formamide solution and incubated overnight at 70 °C.
Washed slices were then incubated overnight with anti
DIG-AP antibody (90 μl/slide). On the third day slices
were washed and developed, moved to PBS in the dark at
RT for 3 h, mounted and imaged.
For the last hour of exposure, the slices were observed
every 10–20 min, and exposure was stopped when back-
ground started to show uniform, ubiquitous, non-specific
DIG signal. Brain structures with a clear DIG signal were
considered positively expressing the probe target, and those
with no significant signal-to-noise ratio were considered
negative for probe target expression.
Quantitative real-time PCR
RNA was extracted using Bio Tri Reagent (Bio-Lab, Ltd.),
and single-stranded cDNA was synthesized from 2 μg
total RNA using High Capacity Reverse Transcriptase Kit
(Applied Biosystems, Foster City, CA, USA).
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The expression of FL and TM was quantified using the
StepOne Plus Real Time PCR System (Applied Biosys-
tems). For each 20 μl qPCR reaction volume, 10 μl Fast
SYBR green master mix (Applied Biosystems), primers at
concentrations chosen in calibration experiments (all from
IDT – Integrated DNA Technologies), 1 μl cDNA (50 ng)
and DDW were mixed together. qPCR was performed at
95° for 20 s followed by 40 cycles of 95° for 3 s and then
60° for 30 s, followed by the melt curve stage. All reactions
were run in triplicate. Data were normalized to the refer-
ence gene GAPDH. All raw data cycle thresholds were
well within the range of reliable detection.
The primers used were as listed below, at final concen-
trations of 500 nM GAPDH and 100 nM RIC-3 isoforms;
signal threshold was set at 0.8. For statistical analysis, raw
CT at threshold was recorded, normalized to GAPDH, and
final expression was calculated as 2-ΔCT.
1. GAPDH forward: CTC TGC TCC TCC CTG
TTC CA
2. GAPDH reverse: CTG GCA CTG CAC AAG
AAG ATG
3. FL forward: AAG CCA CCA AGG AAA ACT
TGC C
4. FL reverse: GCT ATG GTA TTG AAC ACA GAG
GAT GCA GAG G
5. TM forward: GCG ATG GAT TTG AAA GGG
CTA CAT GA
6. TM reverse: CCA GAT CAT TCC AAT CTA TGG
CTT TGG
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Additional file 1: Figure S1. Mouse ric-3 isoforms according to sequences
of full length transcripts. Shaded - ORF, black & white lines – hydrophobic
regions (the first hydrophobic region is likely to function as a signal peptide),
black coil-coiled domain. Empty rectangle - 3’ UTR. Intron size is not to scale.
Asterisk marks site of an extra amino acid (serine) in the edited transcript. 1)
AK138461 encoding for the FL isoform. 2) AK134663 similar to the FL isoform
but edited and with a longer UTR; it is unknown if all edited transcripts have
longer 3′ UTRs. 3) AK082275 and AK053760. 4) AK038724 encoding for the TM
isoform. (PDF 165 kb)
Additional file 2: Figure S2. Effects of FL human RIC-3 vs. mouse FL on
α7 nAChR functional expression in X. leavis oocytes. Results were normalized
to currents recorded in oocytes expressing the respective receptors in the
absence of RIC-3 in the same experiment. Each bar represents 10–20
oocytes from 2 to 3 independent X. laevis. The y-axis ordinates are on a log
scale. * indicates a p value of less than 0.05; ** indicates a p value of less
than 0.01. (PDF 714 kb)
Abbreviations
ACh: acetylcholine; cerb: cerebellum; CNS: central nervous system; FL: full
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